|
市場調査レポート
商品コード
1782642
コンパニオンアニマル用薬剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測Global Companion Animal Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033 |
||||||
カスタマイズ可能
|
|||||||
| コンパニオンアニマル用薬剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測 |
|
出版日: 2025年08月01日
発行: Value Market Research
ページ情報: 英文 161 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
コンパニオンアニマル用薬剤の世界市場規模は、2024年の191億2,000万米ドルから2033年には338億4,000万米ドルに成長し、2026～2033年の予測期間中に6.55％の堅調な年間平均成長率（CAGR）を示すと予測されます。
コンパニオンアニマル用薬剤市場は、ペット飼育の増加と動物の健康とウェルネスに対する意識の高まりに牽引され、大きな成長を遂げています。ペットを生活に迎え入れる家庭が増えるにつれ、獣医療サービスや製品に対する需要が急増しています。ペットの飼い主は予防医療を積極的に求めるようになり、ワクチン、診断、治療市場の拡大につながっています。この動向は、ペットの飼育率が高い地域で特に顕著であり、消費者は動物の健康と福祉に投資することを厭わないです。市場が進化を続ける中、獣医療と技術における革新は、コンパニオンアニマルに利用可能なケアの質を高めると予想されます。
さらに、ペットの人間化の動向がコンパニオンアニマル用薬剤市場に大きな影響を与えています。ペットが家族の一員とみなされるようになり、飼い主は人間のヘルスケア基準に準じた質の高い医療を求めています。このシフトは、コンパニオンアニマル特有のニーズに合わせた特殊な手術、歯科治療、栄養補助食品などの先進的治療に対する需要を促進しています。さらに、獣医療における遠隔医療の台頭は、ペットの飼い主が専門家のアドバイスやサービスにアクセスすることを容易にし、市場をさらに拡大しています。ペットの健康とウェルネスへの注目が高まり続ける中、コンパニオンアニマル用薬剤市場は、ペットの飼い主の進化するニーズに応え、成長すると予想されます。
さらに、研究開発の進歩がコンパニオンアニマル用薬剤市場を強化しています。新しい医薬品、生物製剤、診断ツールの出現は、ペットの様々な症状の診断・治療能力を向上させています。獣医の専門家がより効果的な治療法を利用できるようになるにつれ、コンパニオンアニマルのケアの質は全体的に向上すると予想されます。さらに、獣医の専門家とペット用品メーカーとの協力関係が深まることで、市場での技術革新が促進され、新しく効果的なソリューションの開発が進んでいます。コンパニオンアニマル用薬剤市場は進化を続けており、質の高い獣医療的ケアに対する需要の増加により、持続的な成長が見込まれます。
当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために細心の注意を払って作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。
市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。
市場力学：市場成長に影響を与える主要促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。
セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。
競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。
市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。
地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。
新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の開発と成長展望に関する洞察を記載しています。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 コンパニオンアニマル用薬剤産業分析
- イントロダクション-市場力学
- 市場促進要因
- 市場抑制要因
- 機会
- 産業動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原料分析
- 原料リスト
- 原料メーカー一覧
- 主要原料の価格動向
- 潜在的バイヤーリスト
- マーケティングチャネル
- 直接マーケティング
- 間接マーケティング
- マーケティングチャネル発展動向
第5章 コンパニオンアニマル用薬剤の世界市場分析：適応症別
- 適応症別概要
- 適応症別過去・予測データ分析
- 感染症
- 皮膚病（皮膚疾患）
- 疼痛
- 整形外科疾患
- 行動障害
- その他（歯科、心臓、妊娠、がん）
第6章 コンパニオンアニマル用医薬品の世界市場分析：投与経路別
- 投与経路別概要
- 投与経路別過去・予測データ分析
- 経口剤
- 注射剤
- 局所投与
第7章 コンパニオンアニマル用薬剤の世界市場分析：動物タイプ別
- 動物タイプ別概要
- 動物タイプ別過去・予測データ分析
- 犬
- 猫
- 馬
- その他のコンパニオンアニマル
第8章 コンパニオンアニマル用薬剤の世界市場分析：流通チャネル別
- 流通チャネル別概要
- 流通チャネル別過去・予測データ分析
- 動物病院
- 動物クリニック
- 小売薬局
第9章 コンパニオンアニマル用薬剤の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米の売上分析
- 概要、歴史的推移と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州の売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他の欧州
- アジア太平洋の売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他のアジア太平洋
- ラテンアメリカの売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他のラテンアメリカ
- 中東・アフリカの売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他の中東・アフリカ
第10章 コンパニオンアニマル用薬剤企業の競合情勢
- コンパニオンアニマル用薬剤市場競合
- 提携・協力・契約
- 合併・買収
- 新製品の上市
- その他の開発
第11章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- Virbac
- Dechra Pharmaceuticals
- Vetoquinol
- Neogen Corporation
- Orion Group
- Norbrook Holdings
- Chanelle Pharma
- HIPRA
- Kyoritsu Seiyaku
- Bioge Ne Sis BagA3
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Indication (USD MN)
- Infectious Diseases Market Sales By Geography (USD MN)
- Dermatologic Diseases (Skin Diseases) Market Sales By Geography (USD MN)
- Pain Market Sales By Geography (USD MN)
- Orthopedic Diseases Market Sales By Geography (USD MN)
- Behavioral Disorders Market Sales By Geography (USD MN)
- Others (Dental, Cardio, Pregnancy, Cancer) Market Sales By Geography (USD MN)
- Analysis By Route of Administration (USD MN)
- Oral Market Sales By Geography (USD MN)
- Injectable Market Sales By Geography (USD MN)
- Topical Market Sales By Geography (USD MN)
- Analysis By Animal Type (USD MN)
- Dogs Market Sales By Geography (USD MN)
- Cats Market Sales By Geography (USD MN)
- Horses Market Sales By Geography (USD MN)
- Other Companion Animals Market Sales By Geography (USD MN)
- Analysis By Distribution Channel (USD MN)
- Veterinary Hospitals Market Sales By Geography (USD MN)
- Veterinary Clinics Market Sales By Geography (USD MN)
- Retail Pharmacies Market Sales By Geography (USD MN)
- Global Companion Animal Medicine Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Companion Animal Medicine Report
- Market Research Process
- Market Research Methodology
- Global Companion Animal Medicine Market Size, By Regions (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Indication
- Market Attractiveness Analysis By Route of Administration
- Market Attractiveness Analysis By Animal Type
- Market Attractiveness Analysis By Distribution Channel
- Market Attractiveness Analysis By Regions
- Value Chain Analysis
- Global Market Analysis By Indication (USD MN)
- Infectious Diseases Market Sales By Geography (USD MN)
- Dermatologic Diseases (Skin Diseases) Market Sales By Geography (USD MN)
- Pain Market Sales By Geography (USD MN)
- Orthopedic Diseases Market Sales By Geography (USD MN)
- Behavioral Disorders Market Sales By Geography (USD MN)
- Others (Dental, Cardio, Pregnancy, Cancer) Market Sales By Geography (USD MN)
- Global Market Analysis By Route of Administration (USD MN)
- Oral Market Sales By Geography (USD MN)
- Injectable Market Sales By Geography (USD MN)
- Topical Market Sales By Geography (USD MN)
- Global Market Analysis By Animal Type (USD MN)
- Dogs Market Sales By Geography (USD MN)
- Cats Market Sales By Geography (USD MN)
- Horses Market Sales By Geography (USD MN)
- Other Companion Animals Market Sales By Geography (USD MN)
- Global Market Analysis By Distribution Channel (USD MN)
- Veterinary Hospitals Market Sales By Geography (USD MN)
- Veterinary Clinics Market Sales By Geography (USD MN)
- Retail Pharmacies Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Global Companion Animal Medicine Market size is anticipated to grow from USD 19.12 Billion in 2024 to USD 33.84 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.55% during the forecast period of 2026 to 2033.
The companion animal medicine market is experiencing significant growth, driven by the increasing pet ownership and the rising awareness of animal health and wellness. As more households welcome pets into their lives, the demand for veterinary services and products is surging. Pet owners are becoming more proactive in seeking preventive care, leading to a growing market for vaccines, diagnostics, and therapeutic treatments. This trend is particularly pronounced in regions with high pet ownership rates, where consumers are willing to invest in the health and well-being of their animals. As the market continues to evolve, innovations in veterinary medicine and technology are expected to enhance the quality of care available for companion animals.
Moreover, the growing trend of pet humanization is significantly influencing the companion animal medicine market. As pets are increasingly viewed as family members, owners are seeking high-quality medical care that mirrors human healthcare standards. This shift is driving demand for advanced treatments, including specialized surgeries, dental care, and nutritional supplements tailored to the unique needs of companion animals. Additionally, the rise of telemedicine in veterinary care is making it easier for pet owners to access professional advice and services, further expanding the market. As the focus on pet health and wellness continues to grow, the companion animal medicine market is expected to thrive, catering to the evolving needs of pet owners.
Furthermore, advancements in research and development are enhancing the companion animal medicine market. The emergence of new pharmaceuticals, biologics, and diagnostic tools is improving the ability to diagnose and treat various conditions in pets. As veterinary professionals gain access to more effective treatment options, the overall quality of care for companion animals is expected to improve. Additionally, the increasing collaboration between veterinary professionals and pet product manufacturers is fostering innovation in the market, leading to the development of new and effective solutions. As the companion animal medicine market continues to evolve, it is likely to witness sustained growth, driven by the increasing demand for high-quality veterinary care.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Indication
- Infectious Diseases
- Dermatologic Diseases (Skin Diseases)
- Pain
- Orthopedic Diseases
- Behavioral Disorders
- Others (Dental, Cardio, Pregnancy, Cancer)
By Route of Administration
- Oral
- Injectable
- Topical
By Animal Type
- Dogs
- Cats
- Horses
- Other Companion Animals
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Retail Pharmacies
- COMPANIES PROFILED
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- Virbac
- Dechra Pharmaceuticals
- Vetoquinol
- Neogen Corporation
- Orion Group
- Norbrook Holdings
- Chanelle Pharma
- HIPRA
- Kyoritsu Seiyaku
- Biogenesis Bago.
- The above list can be customized.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. COMPANION ANIMAL MEDICINE INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Animal Type
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Regions
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY INDICATION
- 5.1. Overview By Indication
- 5.2. Historical and Forecast Data Analysis By Indication
- 5.3. Infectious Diseases Historic and Forecast Sales By Regions
- 5.4. Dermatologic Diseases (Skin Diseases) Historic and Forecast Sales By Regions
- 5.5. Pain Historic and Forecast Sales By Regions
- 5.6. Orthopedic Diseases Historic and Forecast Sales By Regions
- 5.7. Behavioral Disorders Historic and Forecast Sales By Regions
- 5.8. Others (Dental, Cardio, Pregnancy, Cancer) Historic and Forecast Sales By Regions
6. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- 6.1. Overview By Route of Administration
- 6.2. Historical and Forecast Data Analysis By Route of Administration
- 6.3. Oral Historic and Forecast Sales By Regions
- 6.4. Injectable Historic and Forecast Sales By Regions
- 6.5. Topical Historic and Forecast Sales By Regions
7. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY ANIMAL TYPE
- 7.1. Overview By Animal Type
- 7.2. Historical and Forecast Data Analysis By Animal Type
- 7.3. Dogs Historic and Forecast Sales By Regions
- 7.4. Cats Historic and Forecast Sales By Regions
- 7.5. Horses Historic and Forecast Sales By Regions
- 7.6. Other Companion Animals Historic and Forecast Sales By Regions
8. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 8.1. Overview By Distribution Channel
- 8.2. Historical and Forecast Data Analysis By Distribution Channel
- 8.3. Veterinary Hospitals Historic and Forecast Sales By Regions
- 8.4. Veterinary Clinics Historic and Forecast Sales By Regions
- 8.5. Retail Pharmacies Historic and Forecast Sales By Regions
9. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL MEDICINE COMPANIES
- 10.1. Companion Animal Medicine Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11. COMPANY PROFILES OF COMPANION ANIMAL MEDICINE INDUSTRY
- 11.1. Top Companies Market Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Zoetis
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
- 11.4. Merck Animal Health
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
- 11.5. Boehringer Ingelheim Animal Health
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
- 11.6. Elanco Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
- 11.7. Ceva SantA(C) Animale
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
- 11.8. Virbac
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
- 11.9. Dechra Pharmaceuticals
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
- 11.10. Vetoquinol
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
- 11.11. Neogen Corporation
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
- 11.12. Orion Group
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
- 11.13. Norbrook Holdings
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
- 11.14. Chanelle Pharma
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
- 11.15. HIPRA
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
- 11.16. Kyoritsu Seiyaku
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
- 11.17. BiogA(C)NA(C)Sis BagA3
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments
